370 related articles for article (PubMed ID: 19887546)
21. Regulation of human nitric oxide synthase 2 expression by Wnt beta-catenin signaling.
Du Q; Park KS; Guo Z; He P; Nagashima M; Shao L; Sahai R; Geller DA; Hussain SP
Cancer Res; 2006 Jul; 66(14):7024-31. PubMed ID: 16849547
[TBL] [Abstract][Full Text] [Related]
22. Docosahexaenoic acid induces proteasome-dependent degradation of beta-catenin, down-regulation of survivin and apoptosis in human colorectal cancer cells not expressing COX-2.
Calviello G; Resci F; Serini S; Piccioni E; Toesca A; Boninsegna A; Monego G; Ranelletti FO; Palozza P
Carcinogenesis; 2007 Jun; 28(6):1202-9. PubMed ID: 17183061
[TBL] [Abstract][Full Text] [Related]
23. Wnt signaling in hepatocellular carcinoma: analysis of mutation and expression of beta-catenin, T-cell factor-4 and glycogen synthase kinase 3-beta genes.
Cui J; Zhou X; Liu Y; Tang Z; Romeih M
J Gastroenterol Hepatol; 2003 Mar; 18(3):280-7. PubMed ID: 12603528
[TBL] [Abstract][Full Text] [Related]
24. Spindle and kinetochore-associated protein 2 facilitates the proliferation and invasion of hepatocellular carcinoma via the regulation of Wnt/β-catenin signaling.
Jiang J; Xu B; Zheng Y; Guo X; Chen F
Exp Cell Res; 2020 Oct; 395(1):112181. PubMed ID: 32682011
[TBL] [Abstract][Full Text] [Related]
25. Endogenous conversion of ω-6 to ω-3 polyunsaturated fatty acids in fat-1 mice attenuated intestinal polyposis by either inhibiting COX-2/β-catenin signaling or activating 15-PGDH/IL-18.
Han YM; Park JM; Cha JY; Jeong M; Go EJ; Hahm KB
Int J Cancer; 2016 May; 138(9):2247-56. PubMed ID: 26650508
[TBL] [Abstract][Full Text] [Related]
26. Alterations of beta-catenin and Tcf-4 instead of GSK-3beta contribute to activation of Wnt pathway in hepatocellular carcinoma.
Cui J; Zhou X; Liu Y; Tang Z; Romeih M
Chin Med J (Engl); 2003 Dec; 116(12):1885-92. PubMed ID: 14687479
[TBL] [Abstract][Full Text] [Related]
27. Glycogen synthase kinase-3 and Axin function in a beta-catenin-independent pathway that regulates neurite outgrowth in neuroblastoma cells.
Orme MH; Giannini AL; Vivanco MD; Kypta RM
Mol Cell Neurosci; 2003 Nov; 24(3):673-86. PubMed ID: 14664817
[TBL] [Abstract][Full Text] [Related]
28. Inhibition of the Wnt/β-catenin signaling pathway improves the anti-tumor effects of sorafenib against hepatocellular carcinoma.
Lin HH; Feng WC; Lu LC; Shao YY; Hsu CH; Cheng AL
Cancer Lett; 2016 Oct; 381(1):58-66. PubMed ID: 27431312
[TBL] [Abstract][Full Text] [Related]
29. Tbx3 is a downstream target of the Wnt/beta-catenin pathway and a critical mediator of beta-catenin survival functions in liver cancer.
Renard CA; Labalette C; Armengol C; Cougot D; Wei Y; Cairo S; Pineau P; Neuveut C; de Reyniès A; Dejean A; Perret C; Buendia MA
Cancer Res; 2007 Feb; 67(3):901-10. PubMed ID: 17283120
[TBL] [Abstract][Full Text] [Related]
30. Connecting COX-2 and Wnt in cancer.
Buchanan FG; DuBois RN
Cancer Cell; 2006 Jan; 9(1):6-8. PubMed ID: 16413466
[TBL] [Abstract][Full Text] [Related]
31. Small molecule antagonists of Tcf4/beta-catenin complex inhibit the growth of HCC cells in vitro and in vivo.
Wei W; Chua MS; Grepper S; So S
Int J Cancer; 2010 May; 126(10):2426-36. PubMed ID: 19662654
[TBL] [Abstract][Full Text] [Related]
32. TRIM66 confers tumorigenicity of hepatocellular carcinoma cells by regulating GSK-3β-dependent Wnt/β-catenin signaling.
Fan W; Du F; Liu X
Eur J Pharmacol; 2019 May; 850():109-117. PubMed ID: 30710548
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of GSK-3beta ameliorates hepatic ischemia-reperfusion injury through GSK-3beta/beta-catenin signaling pathway in mice.
Xia YX; Lu L; Wu ZS; Pu LY; Sun BC; Wang XH
Hepatobiliary Pancreat Dis Int; 2012 Jun; 11(3):278-84. PubMed ID: 22672822
[TBL] [Abstract][Full Text] [Related]
34. Omega-3 polyunsaturated fatty acid inhibits the malignant progression of hepatocarcinoma by inhibiting the Wnt/β-catenin pathway.
Chang FZ; Wang Q; Zhang Q; Chang LL; Li W
Eur Rev Med Pharmacol Sci; 2018 Jul; 22(14):4500-4508. PubMed ID: 30058686
[TBL] [Abstract][Full Text] [Related]
35. Role of omega-3 polyunsaturated fatty acids on cyclooxygenase-2 metabolism in brain-metastatic melanoma.
Denkins Y; Kempf D; Ferniz M; Nileshwar S; Marchetti D
J Lipid Res; 2005 Jun; 46(6):1278-84. PubMed ID: 15772428
[TBL] [Abstract][Full Text] [Related]
36. The cell cycle effects of docosahexaenoic acid on human metastatic hepatocellular carcinoma proliferation.
Lee CY; Sit WH; Fan ST; Man K; Jor IW; Wong LL; Wan ML; Tan-Un KC; Wan JM
Int J Oncol; 2010 Apr; 36(4):991-8. PubMed ID: 20198345
[TBL] [Abstract][Full Text] [Related]
37. Analysis of the Wnt/B-catenin/TCF4 pathway using SAGE, genome-wide microarray and promoter analysis: Identification of BRI3 and HSF2 as novel targets.
Kavak E; Najafov A; Ozturk N; Seker T; Cavusoglu K; Aslan T; Duru AD; Saygili T; Hoxhaj G; Hiz MC; Unal DO; Birgül-Iyison N; Ozturk M; Koman A
Cell Signal; 2010 Oct; 22(10):1523-35. PubMed ID: 20538055
[TBL] [Abstract][Full Text] [Related]
38. Dickkopf 4 (DKK4) acts on Wnt/β-catenin pathway by influencing β-catenin in hepatocellular carcinoma.
Fatima S; Lee NP; Tsang FH; Kolligs FT; Ng IO; Poon RT; Fan ST; Luk JM
Oncogene; 2012 Sep; 31(38):4233-44. PubMed ID: 22249261
[TBL] [Abstract][Full Text] [Related]
39. n-3 PUFAs reduce VEGF expression in human colon cancer cells modulating the COX-2/PGE2 induced ERK-1 and -2 and HIF-1alpha induction pathway.
Calviello G; Di Nicuolo F; Gragnoli S; Piccioni E; Serini S; Maggiano N; Tringali G; Navarra P; Ranelletti FO; Palozza P
Carcinogenesis; 2004 Dec; 25(12):2303-10. PubMed ID: 15358633
[TBL] [Abstract][Full Text] [Related]
40. Low-density lipoprotein docosahexaenoic acid nanoparticles induce ferroptotic cell death in hepatocellular carcinoma.
Ou W; Mulik RS; Anwar A; McDonald JG; He X; Corbin IR
Free Radic Biol Med; 2017 Nov; 112():597-607. PubMed ID: 28893626
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
